« Back to Record
Citation APA

Gillessen, S., Gallardo, E., Choudhury, A., Saad, F., Soares, A., Loriot, Y., McDermott, R., Rodriguez-Vida, A., Velho, P. I., Nolè, F., Cruz, F., Roumeguere, T., Daugaard, G., Yamamura, R., Bompas, E., Maroto, P., Gómez Veiga, F., Skoneczna, I., Martins da Trindade, K., Mavignier Carcano, F., Lecouvet, F., Coens, C., Poncet, C., Fournier, B., & Tombal, B. (2026). Final overall survival results from EORTC 1333/PEACE-3 trial of enzalutamide plus radium-223 in metastatic castration-resistant prostate cancer. Annals of oncology, 37(5), 736-742. doi:10.1016/j.annonc.2026.02.009


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/408988

Gillessen, S., Gallardo, E., Choudhury, A., Saad, F., Soares, A., Loriot, Y., McDermott, R., Rodriguez-Vida, A., Velho, P. I., Nolè, F., Cruz, F., Roumeguere, T., Daugaard, G., Yamamura, R., Bompas, E., Maroto, P., Gómez Veiga, F., Skoneczna, I., Martins da Trindade, K., Mavignier Carcano, F., Lecouvet, F., Coens, C., Poncet, C., Fournier, B., & Tombal, B. (2026). Final overall survival results from EORTC 1333/PEACE-3 trial of enzalutamide plus radium-223 in metastatic castration-resistant prostate cancer. Annals of oncology, 37(5), 736-742. doi:10.1016/j.annonc.2026.02.009